Detalhe da pesquisa
1.
Retrospective registry of patients with locally advanced/metastatic HR+/HER2- breast cancer treated in clinical practice in Andalusia.
Clin Transl Oncol
; 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38831191
2.
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.
J Clin Oncol
; 42(11): 1288-1300, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301187
3.
Real-world experience with pertuzumab and trastuzumab combined with chemotherapy in neoadjuvant treatment for patients with early-stage HER2-positive breast cancer: the NEOPERSUR study.
Clin Transl Oncol
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38538968
4.
New insights into the role of the immune microenvironment in breast carcinoma.
Clin Dev Immunol
; 2013: 785317, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23861693
5.
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Clin Transl Oncol
; 25(9): 2647-2664, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37326826
6.
Role of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implications.
Clin Dev Immunol
; 2012: 756353, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927872
7.
Genes Involved in Immune Reinduction May Constitute Biomarkers of Response for Metastatic Melanoma Patients Treated with Targeted Therapy.
Biomedicines
; 10(2)2022 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35203494
8.
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021).
Clin Transl Oncol
; 24(4): 724-732, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230619
9.
Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms.
Clin Dev Immunol
; 2011: 174149, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22162710
10.
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Sci Rep
; 11(1): 14426, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34257359
11.
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial.
Cancers (Basel)
; 13(18)2021 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572849
12.
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study.
Cancers (Basel)
; 13(21)2021 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771596
13.
Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.
J Biomed Biotechnol
; 20102010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20814546
14.
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy.
Transl Cancer Res
; 8(1): 59-65, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35116734
15.
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022).
Clin Transl Oncol
; 26(2): 555-556, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902930
16.
SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
Clin. transl. oncol. (Print)
; 25(9): 2647-2664, sept. 2023. ilus, tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-224131
17.
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)
Clin. transl. oncol. (Print)
; 24(4): 724-732, abril 2022. tab
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-203776
18.
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
Sci Rep
; 11(1): 17639, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462490
19.
Role of transforming growth factor beta in cancer microenvironment.
Clin Transl Oncol
; 11(11): 715-20, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917534
20.
Correction: SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022)
Clin. transl. oncol. (Print)
; 26(2): 555-556, feb. 2024.
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-230201